Predictions
Wesdome Gold Mines
Start price
Target price
Perf. (%)
€4.65
22.01.23
22.01.23
-
22.01.24
22.01.24
21.71%
24.04.23
24.04.23
Probably not worthwhile Investment
Tellurian Inc
Start price
Target price
Perf. (%)
€1.68
22.01.23
22.01.23
-
22.01.24
22.01.24
-21.28%
24.04.23
24.04.23
Probably not worthwhile Investment
Adobe Inc.
Start price
Target price
Perf. (%)
€325.55
21.01.23
21.01.23
€330.00
21.01.24
21.01.24
72.02%
22.01.24
22.01.24
Could be worthwhile Investment >10% per year
Mercedes-Benz Group AG
Start price
Target price
Perf. (%)
€66.49
21.01.23
21.01.23
€70.00
21.07.23
21.07.23
6.32%
21.07.23
21.07.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
overvalued
Solaredge Technologies Inc
Start price
Target price
Perf. (%)
€270.95
21.01.23
21.01.23
€290.00
21.01.24
21.01.24
-76.13%
22.01.24
22.01.24
Could be worthwhile Investment >10% per year
Synopsys Inc.
Start price
Target price
Perf. (%)
€315.65
21.01.23
21.01.23
€330.00
21.01.24
21.01.24
50.99%
22.01.24
22.01.24
Could be worthwhile Investment >10% per year
Deutsche Cannabis AG
Start price
Target price
Perf. (%)
€0.58
21.01.23
21.01.23
-
31.05.24
31.05.24
-
25.01.23
25.01.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
21.01.23
21.01.23
-
24.05.24
24.05.24
-
26.01.23
26.01.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Sixt SE ST
Start price
Target price
Perf. (%)
€105.50
21.01.23
21.01.23
-
24.05.24
24.05.24
13.65%
04.02.23
04.02.23
EBIT growth >5% per year expected
Top Rating
Very valuable balance sheet
Normal challenges to pay loans and raise capital
flatexDEGIRO AG
Start price
Target price
Perf. (%)
€7.95
21.01.23
21.01.23
-
10.05.24
10.05.24
2.09%
13.02.23
13.02.23
EBIT growth > 30% per year expected
Known brand
Future proof or reliable business model
Higher EBIT margin than peer group
Oric Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.20
20.01.23
20.01.23
€8.00
30.04.25
30.04.25
-27.74%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Immunic Inc.
Start price
Target price
Perf. (%)
€1.69
20.01.23
20.01.23
€3.00
31.10.25
31.10.25
73.12%
06.02.23
06.02.23
Could be very worthwhile Investment >20% year
Rekor Systems Inc.
Start price
Target price
Perf. (%)
€1.65
19.01.23
19.01.23
-
19.01.24
19.01.24
-44.95%
24.04.23
24.04.23
Risky Investment
Citius Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.16
19.01.23
19.01.23
-
19.01.24
19.01.24
12.98%
24.04.23
24.04.23
Probably not worthwhile Investment
Northern Data AG
Start price
Target price
Perf. (%)
€10.35
19.01.23
19.01.23
-
19.01.24
19.01.24
83.96%
24.04.23
24.04.23
Probably not worthwhile Investment
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.45
19.01.23
19.01.23
-
19.01.24
19.01.24
-39.83%
24.04.23
24.04.23
Probably not worthwhile Investment
Paragon AG
Start price
Target price
Perf. (%)
€4.72
19.01.23
19.01.23
-
19.01.24
19.01.24
-29.45%
20.01.24
20.01.24
Could be worthwhile Investment >10% per year
Deutsche Pfandbriefbank AG
Start price
Target price
Perf. (%)
€8.48
19.01.23
19.01.23
€9.00
19.01.24
19.01.24
-25.18%
20.12.23
20.12.23
Medium risks for its business
Fair valuation
Good culture
Henkel AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€66.16
19.01.23
19.01.23
-
09.02.26
09.02.26
1.24%
14.02.23
14.02.23
Infineon Technologies AG
Start price
Target price
Perf. (%)
€32.19
19.01.23
19.01.23
-
19.02.23
19.02.23
2.52%
26.01.23
26.01.23
Could be very worthwhile Investment >20% year
Fair valuation
Leading role in innovation
Very small cyclical dependencies